ScopeUniversitätsklinikum Bonn Institut für Experimentelle Hämatologie und Transfusionsmedizin
171 capabilities
Accredited since June 2025
Verified May 2026
One of 3,188 in Germany
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Venusberg-Campus 1
Bonn 53127 , Germany
Bonn 53127 , Germany
Accreditation
Active
DAkkS
D-ML-13125-01-00
Provides clinical laboratory services spanning clinical chemistry, immunology, molecular human genetics, microbiology, virology, and transfusion medicine, with capabilities in real-time PCR molecular analysis, high-performance liquid chromatography detection, and aggregometry testing.
Accreditation Details
Accreditation Body
DAkkS
Number
D-ML-13125-01-00
Status
ActiveSince
20 June 2025
Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official DAkkS records.
Download Scope PDF
Test Capabilities (171)
| Standard Reference | Description | Category |
|---|---|---|
| (IgG / IgM) | Cardiolipin-Antikörper (IgG/IgM) | Biocompatibility (ISO 10993) |
| Anti körper | Thrombozytäre Antikörper | Biocompatibility (ISO 10993) |
| Rhesus-Untergruppen | Rhesus-Untergruppen | Biological / Microbiological |
| (Apixaban) | (Apixaban) | Clinical Chemistry |
| (Edoxaban) | (Edoxaban) | Clinical Chemistry |
| (Fondaparinux) | Anti-Faktor-Xa-Aktivität (Fondaparinux) | Clinical Chemistry |
| (PAP) | Prostata Phosphatase (PAP) | Clinical Chemistry |
| (Rivaroxaban) | (Rivaroxaban) | Clinical Chemistry |
| (VWF:Ac) | (VWF:CB) | Clinical Chemistry |
| (aPTT) | Thromboplastinzeit (aPTT) | Clinical Chemistry |
| AFP | AFP | Clinical Chemistry |
| APC - Resistenz | APC-Resistenz | Clinical Chemistry |
| Alpha-2-Anti-Plasmin-Aktivität | Alpha-2-Anti-Plasmin-Aktivität | Clinical Chemistry |
| Anti-Thrombin-Aktivität | Antithrombin-Aktivität | Clinical Chemistry |
| Antithrombin-Antigen | Antithrombin-Antigen | Clinical Chemistry |
| Chromogen | Faktor IX chromogen | Clinical Chemistry |
| Collagen-binding-assay | Collagen-binding-assay | Clinical Chemistry |
| Cystein | Homocystein | Clinical Chemistry |
| D-Dimer-Konzentration | D-Dimer-Konzentration | Clinical Chemistry |
| Direkte Faktor-Xa-Inhibitoren | Direkte Faktor-Xa-Inhibitoren | Clinical Chemistry |
| Emicizumab | Emicizumab | Clinical Chemistry |
| Faktor II - Aktivität | Faktor II-Aktivität | Clinical Chemistry |
| Faktor IX Hemmkörper | Faktor IX-Hemmkörper | Clinical Chemistry |
| Faktor V - Aktivität | Faktor V-Aktivität | Clinical Chemistry |
| Faktor VII - Aktivität | Faktor VII-Aktivität | Clinical Chemistry |
| Faktor VIII Hemmkörper | Faktor VIII Hemmkörper | Clinical Chemistry |
| Faktor X - Aktivität | Faktor X-Aktivität | Clinical Chemistry |
| Faktor XI - Aktivität | Faktor XI-Aktivität | Clinical Chemistry |
| Faktor XII - Aktivität | Faktor XII-Aktivität | Clinical Chemistry |
| Faktor XIII - Aktivität | Faktor XIII-Aktivität | Clinical Chemistry |
| Faktor XIII Antigen | Faktor XIII Antigen | Clinical Chemistry |
| Faktor-VIII Clotting "Na" | Faktor-VIII Clotting "Na" | Clinical Chemistry |
| Fibrinogen -Antigen | Fibrinogen Antigen | Clinical Chemistry |
| Fibrinogenaktivität | Fibrinogenaktivität | Clinical Chemistry |
| Gerinnungsfaktor VIII Chromogen | Gerinnungsfaktor VIII Chromogen | Clinical Chemistry |
| HMWK-Aktivität | HMWK-Aktivität | Clinical Chemistry |
| LP (a) | Lipoprotein A Lp(a) | Clinical Chemistry |
| Lupus sensitive APTT | Lupus-sensitive aPTT | Clinical Chemistry |
| PAI Antigen | PAI-Antigen | Clinical Chemistry |
| PAI-Aktivität | PAI-Aktivität | Clinical Chemistry |
| Plasmin-alpha-2-Antiplasminkomplexe | Plasmin-alpha-2-Antiplasminkomplexe | Clinical Chemistry |
| Plasminogen Aktivität | Plasminogen Aktivität | Clinical Chemistry |
| Protein C - Aktivität | Protein C-Aktivität | Clinical Chemistry |
| Protein C Antigen | Protein C Antigen | Clinical Chemistry |
| Prothrombinfragment 1+2 | Prothrombinfragment 1+2 | Clinical Chemistry |
| Präkallikrein-Aktivität | Präkallikrein-Aktivität | Clinical Chemistry |
| Reptilase-Zeit | Reptilasezeit | Clinical Chemistry |
| Thrombelastographie (NATEM) | Thrombelastographie (NATEM) | Clinical Chemistry |
| Thrombin-Antithrombin-Komplexe | Thrombin-Antithrombin-Komplexe | Clinical Chemistry |
| VWF-Aktivität | vWF-Aktivität | Clinical Chemistry |
| t-PA Antigen | t-PA-Antigen | Clinical Chemistry |
| unfraktioniertes Heparin (aPTT) | unfraktioniertes Heparin (aPTT) | Clinical Chemistry |
| vWF-Antigen | vWF-Antigen | Clinical Chemistry |
| Differential Blutbild | Differentialblutbild | Elemental Analysis |
| PROC-Gen | PROC-Gen | Elemental Analysis |
| PROS1-Gen | PROS1-Gen | Elemental Analysis |
| Erythrozytä re Antigene | Erythrozytäre Antigene | Food Safety Testing |
| AB-D | ABD | Hematology |
| Erythrozyten (RBC) | Erythrozyten (RBC) | Hematology |
| Granulozyten und Monozyten | Granulozyten und Monozyten | Hematology |
| Hämoglobin (HGB) | Hämoglobin (HGB) | Hematology |
| Hämoglobin (Spendereignung) | Hämoglobin (Spendereignung) | Hematology |
| Kell-System | Kell-System | Hematology |
| Kreuzprobe | Kreuzprobe | Hematology |
| Leukozyten (WBC) | Leukozyten (WBC) | Hematology |
| Leukozytenzahl | Leukozytenzahl | Hematology |
| Reti kulozyten | Retikulozyten | Hematology |
| Thrombinzeit | Thrombinzeit | Hematology |
| Thrombozyten- Aggregation | Thrombozytenaggregation | Hematology |
| (CD42b, CD41a, CD62) | (CD42b, CD41a, CD62) | Immunology / Serology |
| (qualitativ und semi-quantitativ) | (qualitativ und semi-quantitativ) | Immunology / Serology |
| 1/2-go-Antikörper+p24Ag | 1/2-go-Antikörper+p24Ag | Immunology / Serology |
| A-Untergruppe | A-Untergruppe | Immunology / Serology |
| ABD-Identitätstest | ABD-Identitätstest | Immunology / Serology |
| ABO-System und Isoagglutinine | ABO-System und Isoagglutinine | Immunology / Serology |
| ADAMTS-13-Antikörper | ADAMTS-13-Antikörper | Immunology / Serology |
| Alloantikörper | gebundene Auto-/Alloantikörper | Immunology / Serology |
| Anti-Heparin-PF4-Antikörper | Anti-Heparin-PF4-Antikörper | Immunology / Serology |
| Anti-Serin-Prothrombin-Antikörper | Anti-Serin-Prothrombin-Antikörper | Immunology / Serology |
| Antihumanglobulintest | Direkter Antihumanglobulintest | Immunology / Serology |
| Antikörper Differenzierung | Antikörperdifferenzierung | Immunology / Serology |
| Antikörper Suchtest | Antikörpersuchtest | Immunology / Serology |
| Antikörper Titer | Hepatitis-B-Antikörper Titer | Immunology / Serology |
| Blutgruppen-Antigene | Komplette Blutgruppenantigene | Immunology / Serology |
| C1 Esterase-Inhibitor-Aktivität | C1-Esterase-Inhibitor-Aktivität | Immunology / Serology |
| CD34+-Zellzahl | CD34+-Zellzahl | Immunology / Serology |
| Erweiterte Diagnostik für freie | Erweiterte Diagnostik für freie | Immunology / Serology |
| Hepatitis B Surface-Antigen | Hepatitis-B-surface-Antigen | Immunology / Serology |
| Hepatitis C Virus Antikörper | Hepatitis-C-Virus-Antikörper | Immunology / Serology |
| Hepatitis-B-core-Antikörper | Hepatitis-B-core-Antikörper | Immunology / Serology |
| Hämolysine | Hämolysine | Immunology / Serology |
| Immunstatus (CD45, CD3/CD19, CD3/CD4, CD3/CD8, CD3/CD56) | Immunstatus (CD45, CD3/CD19, CD3/CD4, CD3/CD8, CD3/CD56) | Immunology / Serology |
| Komplementaktivierende HLA-Klasse | Komplementaktivierende HLA-Klasse | Immunology / Serology |
| Medikamenten-abhängige | Medikamenten-abhängige | Immunology / Serology |
| Partielle Thromboplastinzeit | Partielle Thromboplastinzeit | Immunology / Serology |
| Phospholipid-Screen IgG/IgM | Phospholipid-Screen IgG/IgM | Immunology / Serology |
| Rhesus-D-Faktor | Rhesus-D-Faktor | Immunology / Serology |
| Thrombozytäre Glykoproteinexpression | Thrombozytäre Glykoproteinexpression | Immunology / Serology |
| (Exone 3 und 7), CYP4F2-Gen | (Exone 3 und 7), CYP4F2-Gen | Molecular Diagnostics / PCR |
| ADAMTS13-Gen | ADAMTS13-Gen | Molecular Diagnostics / PCR |
| Defekt; Gene: P2RY12, P2RY1, | Defekt; Gene: P2RY12, P2RY1, | Molecular Diagnostics / PCR |
| EPCR (PROCR-Gen) | EPCR (PROCR-Gen) | Molecular Diagnostics / PCR |
| Erythrozytäre | Zygosität/Spezielle erythrozytäre | Molecular Diagnostics / PCR |
| F10-Gen | F10-Gen | Molecular Diagnostics / PCR |
| F11-Gen | F11-Gen | Molecular Diagnostics / PCR |
| F12-Gen | F12-Gen | Molecular Diagnostics / PCR |
| F13A und F13B-Gene | F13A und F13B-Gene | Molecular Diagnostics / PCR |
| F2-Gen | F2-Gen | Molecular Diagnostics / PCR |
| F5-Gen | F5-Gen | Molecular Diagnostics / PCR |
| F7-Gen | F7-Gen | Molecular Diagnostics / PCR |
| F8-Gen | F8-Gen | Molecular Diagnostics / PCR |
| F8-Gen, Intron 1 Inversion, Inversion | F8-Gen, Intron 1 Inversion, Inversion | Molecular Diagnostics / PCR |
| F9-Gen | F9-Gen | Molecular Diagnostics / PCR |
| Faktor V-Mutation (G1691A) | Faktor V-Mutation (G1691A) | Molecular Diagnostics / PCR |
| GATA1, VPS33B, VIPAS39, FLI1, MLPH, RAB27A, MYO5A | GATA1, VPS33B, VIPAS39, FLI1, MLPH, RAB27A, MYO5A | Molecular Diagnostics / PCR |
| GGCX-Gen | GGCX-Gen | Molecular Diagnostics / PCR |
| GP5, CD36, TBXA2R, ITGA2B, ITGA2, vWF | GP5, CD36, TBXA2R, ITGA2B, ITGA2, vWF | Molecular Diagnostics / PCR |
| GP9, GP1BA, GP1BB, FERMT3 | GP9, GP1BA, GP1BB, FERMT3 | Molecular Diagnostics / PCR |
| HBV-DNA (Einzeltestung, Pooltestung) | HBV-DNA (Einzeltestung, Pooltestung) | Molecular Diagnostics / PCR |
| HCV-RNA (Einzeltestung, Pooltestung) | HCV-RNA (Einzeltestung, Pooltestung) | Molecular Diagnostics / PCR |
| HEV-RNA (Einzeltestung, Pooltestung) | HEV-RNA (Einzeltestung, Pooltestung) | Molecular Diagnostics / PCR |
| HIV-1/2-RNA (Einzeltestung, Pooltestung) | HIV-1/2-RNA (Einzeltestung, Pooltestung) | Molecular Diagnostics / PCR |
| HPA (1,2,3,4,5,6,9 und 15)-Typ | HPA (1,2,3,4,5,6,9 und 15)-Typ | Molecular Diagnostics / PCR |
| KLKB1-Gen | KLKB1-Gen | Molecular Diagnostics / PCR |
| KNG1-Gen | KNG1-Gen | Molecular Diagnostics / PCR |
| LMAN1 und MCFD2-Gene | LMAN1 und MCFD2-Gene | Molecular Diagnostics / PCR |
| MTHFR C677T-Polymorphismus | MTHFR C677T-Polymorphismus | Molecular Diagnostics / PCR |
| NGS Panel 1 - Störungen der | NGS Panel 1 - Störungen der | Molecular Diagnostics / PCR |
| NGS Panel 2 - Thrombozyten-Rezeptor | NGS Panel 2 - Thrombozyten-Rezeptor | Molecular Diagnostics / PCR |
| NGS Panel 3 - Störungen der | NGS Panel 3 - Störungen der | Molecular Diagnostics / PCR |
| NGS Panel 4 - Thrombozytopathien | NGS Panel 4 - Thrombozytopathien | Molecular Diagnostics / PCR |
| NGS Panel 5 - Andere | NGS Panel 5 - Andere | Molecular Diagnostics / PCR |
| NGS Panel 6 - Störungen der | NGS Panel 6 - Störungen der | Molecular Diagnostics / PCR |
| PAI-I (SERPINE1-Gen) | PAI-I (SERPINE1-Gen) | Molecular Diagnostics / PCR |
| Partial, RHCE, RH Dweak/Dparital | Partial, RHCE, RH Dweak/Dparital | Molecular Diagnostics / PCR |
| Plasminogen (PLG-Gen) | Plasminogen (PLG-Gen) | Molecular Diagnostics / PCR |
| Polymorphismus, FV-Leiden | Polymorphismus, FV-Leiden | Molecular Diagnostics / PCR |
| SERPINC1-Gen | SERPINC1-Gen | Molecular Diagnostics / PCR |
| Signaltransduktion; Gene: GNA13, GNAS, PLA2G7, DHCR24, ADRA2A, RASGRP2 | Signaltransduktion; Gene: GNA13, GNAS, PLA2G7, DHCR24, ADRA2A, RASGRP2 | Molecular Diagnostics / PCR |
| THBD-Gen | THBD-Gen | Molecular Diagnostics / PCR |
| Thrombophilie Polymorphismen | Thrombophilie Polymorphismen | Molecular Diagnostics / PCR |
| Thrombozytenadhäsion; Gene: | Thrombozytenadhäsion; Gene: | Molecular Diagnostics / PCR |
| Thrombozytensekretion; Gene: | Thrombozytensekretion; Gene: | Molecular Diagnostics / PCR |
| VKORC1-Gen | VKORC1-Gen | Molecular Diagnostics / PCR |
| VKORC1-Gen Promoter, CYP2C9-Gen | VKORC1-Gen Promoter, CYP2C9-Gen | Molecular Diagnostics / PCR |
| West Nile Virus (Einzeltestung, Pooltestung) | West Nile Virus (Einzeltestung, Pooltestung) | Molecular Diagnostics / PCR |
| Zytoskelettdefekten; Gene: | Zytoskelettdefekten; Gene: | Molecular Diagnostics / PCR |
| vWF-Gen | vWF-Gen | Molecular Diagnostics / PCR |
| Anti-Faktor-Xa-Aktivität (NM | Anti-Faktor-Xa-Aktivität (NM | Other |
| Crossmatch (serologische | Crossmatch (serologische | Other |
| Faktor-VIII-Aktivität (Pathromtin | Faktor-VIII-Aktivität (Pathromtin | Other |
| HbF | HbF | Other |
| System) | Verträglichkeitsprobe im HLA-System) | Other |
| Freies Protein-S Antigen | Freies Protein-S Antigen | Spectroscopy (XRF, ICP, AAS) |
| Treponema pallidum Antikörper | Treponema pallidum-Antikörper | Sterility Testing |
| (Actin FS) | Faktor-IX-Aktivität (Actin FS) | Temperature / Pressure |
| (FLAER/CD157) | (FLAER/CD157) | Temperature / Pressure |
| (eingesetzte Agonisten: ADP, Kollagen, Ristocetin, Arachidonsäure) | (eingesetzte Agonisten: ADP, Kollagen, Ristocetin, Arachidonsäure) | Temperature / Pressure |
| Agonisten: ADP, ADP-PGE1, | Agonisten: ADP, ADP-PGE1, | Temperature / Pressure |
| Aktivierte partielle Thromboplastinzeit | Aktivierte partielle Thromboplastinzeit | Temperature / Pressure |
| Erythrozyten (CD59/CD55) | Erythrozyten (CD59/CD55) | Temperature / Pressure |
| Faktor-VIII-Aktivität (Actin | Faktor-VIII-Aktivität (Actin | Temperature / Pressure |
| Heparin induzierter Thrombozytopenie | Heparin induzierter Thrombozytopenie | Temperature / Pressure |
| Hämatokrit (HCT) | Hämatokrit (HCT) | Temperature / Pressure |
| Phosphatidylinositol (GPI) und | Phosphatidylinositol (GPI) und | Temperature / Pressure |
| Thrombozyten (PLT) | Thrombozyten (PLT) | Temperature / Pressure |
| Typ II (HIT II) | Typ II (HIT II) | Temperature / Pressure |
| VWF-Multimere | vWF-Multimere | Temperature / Pressure |
| dRVV-Screen/confirm | dRVV-Screen/confirm | Temperature / Pressure |
| heparininduzierter Antikörper | heparininduzierter Antikörper | Temperature / Pressure |
| verankerten Molekülen auf | verankerten Molekülen auf | Temperature / Pressure |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.